Page last updated: 2024-10-22

anastrozole and Carcinoma, Non-Small Cell Lung

anastrozole has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Lung cancer is the most common cancer in the world."1.33Aromatase inhibitors in human lung cancer therapy. ( Dubinett, SM; Fishbein, MC; Garban, HJ; Goodglick, L; Marquez-Garban, DC; Pietras, RJ; Weinberg, OK, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shen, L1
Li, Z2
Shen, S1
Niu, X1
Yu, Y1
Liao, M1
Chen, Z1
Lu, S1
Weinberg, OK1
Marquez-Garban, DC1
Fishbein, MC1
Goodglick, L1
Garban, HJ1
Dubinett, SM1
Pietras, RJ1

Other Studies

2 other studies available for anastrozole and Carcinoma, Non-Small Cell Lung

ArticleYear
The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.
    Lung cancer (Amsterdam, Netherlands), 2012, Volume: 78, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Carcinoma, Non-Small-Cell Lung;

2012
Aromatase inhibitors in human lung cancer therapy.
    Cancer research, 2005, Dec-15, Volume: 65, Issue:24

    Topics: Anastrozole; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Carcinoma, Non-Small-Cell Lu

2005